Dashboard
Manage Tickers

MRVI MARAVAI LIFESCIENCES HOLDIN...

Nasdaq maravai.com


$ 2.88 $ -0.02 (-0.69 %)    

Friday, 07-Nov-2025 16:23:32 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.87
$ 2.58
$ 2.52 x 5
$ 2.95 x 19
$ 2.55 - $ 2.91
$ 1.67 - $ 6.34
1,363,678
na
733.88M
$ 1.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-18-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-22-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

maravai-lifesciences-q3-adj-eps-008-inline-sales-41630m-miss-49003m-estimate
Maravai LifeSciences Q3 Adj. EPS $(0.08), ...
11/06/2025 21:04:03

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. Thi...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

rbc-capital-maintains-outperform-on-maravai-lifesciences-lowers-price-target-to-5
RBC Capital Maintains Outperform on Marava...
08/12/2025 14:06:24

RBC Capital analyst Conor McNamara maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and lowers the price targe...

maravai-lifesciences-q2-adj-eps-008-misses-007-estimate-sales-4740m-inline
Maravai LifeSciences Q2 Adj. EPS $(0.08) M...
08/11/2025 20:07:47

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

what-to-expect-from-maravai-lifesciencess-earnings
What to Expect from Maravai LifeSciences's...
08/08/2025 19:07:09

maravai-lifesciences-appoints-rajesh-asarpota-as-cfo-effective-june-30-2025
Maravai LifeSciences Appoints Rajesh Asarp...
06/25/2025 20:01:58

maravai-lifesciences--announces-the-appointment-of-bernd-brust-as-chief-executive-officer-effective-immediately
Maravai LifeSciences Announces The Appoin...
06/09/2025 12:36:37

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and b...

maravai-lifesciences-trilink-signs-non-exclusive-license-and-supply-agreement-with-quantoom-biosciences-for-cleancap-mrna-capping-technology
Maravai LifeSciences' TriLink Signs Non-Ex...
06/03/2025 14:02:12

trilink-biotechnologies-releases-its-first-mrna-synthesis-kit-with-cleancap-capping-technology
Trilink Biotechnologies Releases Its First...
05/20/2025 12:10:44

New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through st...

trilink-and-ivi-collaborate-to-advance-research-and-development-of-mrna-based-vaccines-and-promote-equitable-access-to-essential-vaccines-and-health-technologies
TriLink and IVI Collaborate To Advance Res...
05/14/2025 20:03:15

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents ...

these-analysts-slash-their-forecasts-on-maravai-lifesciences-following-q1-results
These Analysts Slash Their Forecasts On Ma...
05/13/2025 17:29:22

craig-hallum-maintains-buy-on-maravai-lifesciences-lowers-price-target-to-10
Craig-Hallum Maintains Buy on Maravai Life...
05/13/2025 17:10:58

Craig-Hallum analyst Christian Schwab maintains Maravai LifeSciences (NASDAQ:MRVI) with a Buy and lowers the price target fr...

assessing-maravai-lifesciences-insights-from-5-financial-analysts
Assessing Maravai LifeSciences: Insights F...
05/13/2025 14:00:24

baird-maintains-neutral-on-maravai-lifesciences-lowers-price-target-to-2
Baird Maintains Neutral on Maravai LifeSci...
05/13/2025 12:30:31

Baird analyst Catherine Schulte maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and lowers the price target from...

maravai-lifesciences-sees-fy2025-sales-guidance-18500m-20500m-vs-19275m-est
Maravai LifeSciences Sees FY2025 Sales Gui...
05/12/2025 20:10:07

maravai-lifesciences-q1-adj-eps-008-misses-007-estimate-sales-4685m-beat-4401m-estimate
Maravai LifeSciences Q1 Adj. EPS $(0.08) M...
05/12/2025 20:08:03

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

insights-ahead-maravai-lifesciencess-quarterly-earnings
Insights Ahead: Maravai LifeSciences's Qua...
05/09/2025 15:02:06

breaking-down-maravai-lifesciences-4-analysts-share-their-views
Breaking Down Maravai LifeSciences: 4 Anal...
03/25/2025 19:01:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION